DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Pina LM, Dong X, Zhang L. et al.
Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: rationale and design of a prospective, randomized trial (the UNIVERSE study).
Am Heart J 2019;
213: 97-104
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.